Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orna Mor

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
BMC Infectious Diseases|March 1, 2018
Characterization of hepatitis B and delta coinfection in IsraelRachel Shirazi, Daniela Ram, Aviya Rakovsky, et al.
Antiviral Therapy|March 19, 2019
High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life dataYael Gozlan, Efrat Bucris, Rachel Shirazi, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antiviralsAnita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
Antiviral Therapy|January 10, 2017
HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patientsYael Gozlan, Ziv Ben-Ari, Roy Moscona, et al.
The Journal of Infectious Diseases|July 3, 2015
Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE)Lucas Etienne Hermans, Valentina Svicher, Suzan Diepstraten Pas, et al.
BMC Infectious Diseases|June 3, 2018
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in EuropeLuna Colagrossi, Lucas E Hermans, Romina Salpini, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Nature Communications|November 17, 2022
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Wellcome Open Research|October 4, 2021
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinchÁine O'Toole, Verity Hill, Oliver G Pybus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
BMC Infectious Diseases|March 1, 2018
Characterization of hepatitis B and delta coinfection in IsraelRachel Shirazi, Daniela Ram, Aviya Rakovsky, et al.
Antiviral Therapy|March 19, 2019
High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life dataYael Gozlan, Efrat Bucris, Rachel Shirazi, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antiviralsAnita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
Antiviral Therapy|January 10, 2017
HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patientsYael Gozlan, Ziv Ben-Ari, Roy Moscona, et al.
The Journal of Infectious Diseases|July 3, 2015
Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE)Lucas Etienne Hermans, Valentina Svicher, Suzan Diepstraten Pas, et al.
BMC Infectious Diseases|June 3, 2018
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in EuropeLuna Colagrossi, Lucas E Hermans, Romina Salpini, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Nature Communications|November 17, 2022
Global disparities in SARS-CoV-2 genomic surveillanceAnderson F Brito, Elizaveta Semenova, Gytis Dudas, et al.
Wellcome Open Research|October 4, 2021
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinchÁine O'Toole, Verity Hill, Oliver G Pybus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 10